Bristol-Myers Squibb Company
PET-imaging immunomodulators

Abstract:

The invention relates to the synthesis and use of .sup.18F-labeled millamolecules for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.